A HIV Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38513236.
- Also identified by DOI 10.1093/cid/ciad757.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A case of a male with human immunodeficiency virus with plasma genotyping detecting no resistance and a CRF02_AG subtype had a controlled HIV RNA on antiretroviral therapy since 2010. We introduced intramuscular therapy with cabotegravir and rilpivirine. One month later, his HIV RNA was 1500 copies/mL; genotyping found a subtype B with many mutations.
Medical subject headings
- Anti-HIV Agents
- HIV Infections
- Pyridones
- Rilpivirine
- Superinfection